Last reviewed · How we verify
Astragalus Membranaceus Root
Astragalus Membranaceus Root is a Small molecule drug developed by Fujian Medical University Union Hospital. It is currently FDA-approved.
Astragalus membranaceus root has been studied in clinical trials for various conditions, including lung cancer, urinary incontinence, ischemic stroke, irritable bowel syndrome, and diarrhea-predominant irritable bowel syndrome. However, the mechanism of action of Astragalus membranaceus root is currently unknown, according to ChEMBL.
At a glance
| Generic name | Astragalus Membranaceus Root |
|---|---|
| Sponsor | Fujian Medical University Union Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease (PHASE1, PHASE2)
- The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula (PHASE2)
- Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway (NA)
- Traditional Chinese Medicine Hand-Foot Soak for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome
- A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery (NA)
- MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits (PHASE2)
- Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling (PHASE2)
- A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Astragalus Membranaceus Root CI brief — competitive landscape report
- Astragalus Membranaceus Root updates RSS · CI watch RSS
- Fujian Medical University Union Hospital portfolio CI
Frequently asked questions about Astragalus Membranaceus Root
What is Astragalus Membranaceus Root?
Who makes Astragalus Membranaceus Root?
What development phase is Astragalus Membranaceus Root in?
Related
- Manufacturer: Fujian Medical University Union Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing